高级检索
当前位置: 首页 > 详情页

Catastrophic health expenditure, incidence, trend and socioeconomic risk factors in China: A systematic review and meta-analysis

文献详情

资源类型:
Pubmed体系:
机构: [1]West China School of Public Health, West China Fourth Hospital, Sichuan University, Chengdu,Sichuan, China, [2]Research Center for Palliative Care, West China-PUMC C.C. Chen Institute ofHealth, Sichuan University, Chengdu, Sichuan, China, [3]West China Research Centre for Rural HealthDevelopment, Sichuan University, Chengdu, Sichuan, China, [4]Faculty of Health, Art and Design,Swinbune Technology University, Melbourne, VIC, Australia, [5]Department of Pharmacy, West ChinaSecond University Hospital, Sichuan University, Chengdu, China, [6]Evidence-Based PharmacyCenter, West China Second University Hospital, Sichuan University, Chengdu, China, [7]NMPA KeyLaboratory for Technical Research on Drug Products In Vitro and In Vivo Correlation, Chengdu,China, [8]Key Laboratory of Birth Defects and Related Diseases of Women and Children, SichuanUniversity, Ministry of Education, Chengdu, China
出处:

关键词: influencing factors systematic review meta-analysis catastrophic health expenditure social-economic risk factors

摘要:
To evaluate the incidence and trend of catastrophic health expenditures (CHE) in China over the past 20 years and explore the socioeconomic factors affecting China's CHE rate.The systematic review was conducted according to the Cochrane Handbook and reported according to PRISMA. We searched English and Chinese literature databases, including PubMed, EMbase, Web of Science, China National Knowledge Infrastructure (CNKI), Wan Fang, China Science and Technology Journal Database (CQVIP), and CBM (Sino Med), for empirical studies on the CHE rate in China and its associated socioeconomic factors from January 2000 to June 2020. Two reviewers conducted the study selection, data extraction, and quality appraisal. The secular trend of the CHE rate was examined, and factors associated with CHE were explored using subgroup analysis and meta-regression.A total of 118 eligible studies with 1,771,726 participants were included. From 2000 to 2020, the overall CHE rate was 25.2% (95% CI: 23.4%-26.9%) in China. The CHE rate continued to rise from 13.0% in 2000 to 32.2% in 2020 in the general population. The CHE rate was higher in urban areas than in rural areas, higher in the western than the northeast, eastern, and central region, in the elderly than non-elderly, in low-income groups than non-low-income groups, in people with cancer, chronic infectious disease, and cardio-cerebrovascular diseases (CCVD) than those with non-chronic disease group, and in people with NCMS than those with URBMI and UEBMI. Multiple meta-regression analyses found that low-income, cancer, CCVD, unspecified medical insurance type, definition 1 and definition 2 were correlated with the CHE rate, while other factors were all non-significantly correlated.In the past two decades, the CHE rate in China has been rising. The continuous rise of health expenditures may be an important reason for the increasing CHE rate. Age, income level, and health status affect the CHE rate. Therefore, it is necessary to find ways to meet the medical needs of residents and, at the same time, control the unreasonable rapid increase in health expenditures in China.Copyright © 2023 Zhang, Jiang, Yang, Zou and Chen.

基金:
语种:
PubmedID:
中科院(CAS)分区:
出版当年[2022]版:
大类 | 3 区 医学
小类 | 3 区 公共卫生、环境卫生与职业卫生
最新[2023]版:
大类 | 3 区 医学
小类 | 3 区 公共卫生、环境卫生与职业卫生
第一作者:
第一作者机构: [1]West China School of Public Health, West China Fourth Hospital, Sichuan University, Chengdu,Sichuan, China, [2]Research Center for Palliative Care, West China-PUMC C.C. Chen Institute ofHealth, Sichuan University, Chengdu, Sichuan, China,
通讯作者:
通讯机构: [1]West China School of Public Health, West China Fourth Hospital, Sichuan University, Chengdu,Sichuan, China, [2]Research Center for Palliative Care, West China-PUMC C.C. Chen Institute ofHealth, Sichuan University, Chengdu, Sichuan, China, [5]Department of Pharmacy, West ChinaSecond University Hospital, Sichuan University, Chengdu, China, [6]Evidence-Based PharmacyCenter, West China Second University Hospital, Sichuan University, Chengdu, China, [7]NMPA KeyLaboratory for Technical Research on Drug Products In Vitro and In Vivo Correlation, Chengdu,China, [8]Key Laboratory of Birth Defects and Related Diseases of Women and Children, SichuanUniversity, Ministry of Education, Chengdu, China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:43377 今日访问量:0 总访问量:3120 更新日期:2024-09-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 四川省肿瘤医院 技术支持:重庆聚合科技有限公司 地址:成都市人民南路四段55号